NCET2 Certified Startup Development Officers

The National Council of Entrepreneurial Tech Transfer (NCET2) has created a capstone program to find Startup Development Officers (SDOs) to assist universities, faculty, researchers, students, and entrepreneurs to develop startups aligned to NCET2's Corporate Members' business units.

SDOs are:
  • Former Fortune 500 executives
  • Angel investors
  • Serial entrepreneurs
  • Startup attorneys
Our SDOs have extensive knowledge and experience in startup development, who sit on adviser boards to guide early-stage startups in exchange for adviser equity in the startups. Time commitment can be as little as 5 hours per month via online communications.

Apply here to be part of our growing SDO network.

Below is a partial representative list of NCET2 SDOs:

Watch the webinar on the Startup Development Officer Program

Download the SDO Webinar Slides
Ashok Agarwala
Ashok Agarwala
SDO - Corporate/Angel/Entrepreneur

Ashok is highly experienced corporate and entrepreneurial leader with passion to venture and grow businesses creating value and enabling exponential growth through innovation. He has worked across consumer, industrial, and enterprise sectors in the US and international markets. He has successfully led growth initiatives and developed new businesses at Fortune 500 corporations including Henkel Corporation, Seagate Technology, and Eastman Kodak adding multi-billion dollars in new revenues to the top line. Ashok brings lot of experience from the startup community as well and on multiple fronts - investment, governance, and operations – all critical success factors. He has actively participated in a private angel investment group and several corporate ventures group and also served on the board and advisory for startups. Interestingly, he has successfully led in forming ecosystem partnerships between market disrupting startups and large established corporations. Complementing Ashok’s professional work experience is his academic background with an MBA and a technical PhD from Carnegie Mellon University.
Mike Alder
Mike Alder
SDO - Corporate/Entrepreneur/VC Investor

G. Michael Alder is Director of the Office Technology Transfer, for Brigham Young University, Provo, Utah (www.techtransfer.byu.edu). He is a voting member of the KickStart Seed Venture Fund investment committee. He is also the Chairman of WestCAMP, Inc and the National Centers of Excellence. In 2006 moved to BYU and retired as a partner with Redmont Venture Partners, Inc. in Birmingham, Alabama and as the Executive Director of the Biotechnology Association of Alabama. In the 10 years he was a partner at Redmont he co founded 9 technology based businesses – two of those companies have now gone public. Overall Mr. Alder has over 35 years of experience in leading technology based startup companies. He was previously CEO of Emerging Technology Partners in Birmingham, Alabama from 1997 to 2003. Prior to coming to Alabama in 1994 he co-founded the Grow Utah Fund that focused on creating technology based businesses in the state of Utah. In 1989 he was asked by the Governor to head the Office of Technology Development for the State of Utah, which he did for 5 years. In 1973 he founded NPI, a plant biotechnology company in Salt Lake City, Utah and served as President, COO and Vice Chairman of that company for 15 years as it grew to over 700 employees. Mr. Alder received a MS in Biology from the University of Utah in 1971.
Samuel Burkholder
Samuel Burkholder
SDO - Startup Attorney

An experienced intellectual property law counselor with a strong background in the chemical arts. He left Big Law and founded his own firm over 10 years ago to escape the overbearing formalities and structure. He is currently working with several inventors/entrepreneurs on patent protection, and both funding and licensing efforts.
Edward Diehl
Edward Diehl
SDO - Entrepreneur

More than 25 years of experience in evaluating and developing life science technologies. Holds a B.S. in Biology from the Pennsylvania State University and a Ph.D. in Physiology and Biophysics from the University of Iowa. He completed a National Cancer Institute-sponsored fellowship in Biochemistry and Molecular Biology at the Mayo Clinic and a fellowship in Pharmacology at Duke University. He was later appointed to two faculty positions – Assistant Professor of Natural and Health Sciences at Barry University and Research Assistant Professor at the Northwestern University School of Medicine. He was subsequently hired as a Senior Scientist in the Diagnostic Division of Abbott Laboratories where his work contributed to the validation and launch of seven cancer diagnostic tests on three instrument platforms. He moved on to entrepreneurial roles at several startups and a CRO where he participated in R&D, investment, licensing, and business and intellectual property development efforts. He was a member of the Technology Evaluation Committee for the Office of Technology Development at the Medical College of Wisconsin and subsequently hired as their Intellectual Property Marketing Manager. In 2008, he launched the Diehl Group which has now become Pathway Biotechnology. In 2017 he became an I-Corps mentor, coaching teams in lean start-methodology.
John Cooper
John Cooper
SDO - Corporate

John is an independent director and consultant to renewable energy, independent power and infrastructure project development ventures. He is also a senior finance executive, CFO, renewable energy entrepreneur, international business and project development expertise. He is the President & CEO of Finance and Energy Advisory Services, LLC, a finance and energy consulting practice providing strategic planning, financial structuring, acquisitions strategies, power purchase/sales negotiations, business planning, equity/debt fundraising, independent directorships and other services to renewable energy, independent power, infrastructure and utility clients. He was a founding member of executive management team of a PG&E/ Bechtel joint venture independent power company, which grew to be a PG&E owned $4 billion energy company. He managed all financial operations including treasury, banking relations, project & corporate financing, and asset acquisitions. Developed and structured more than $10 billion in project and corporate financing, winning numerous “deal of the year” awards for innovations in structured finance.
Robert Hisrich
Robert Hisrich
SDO - Angel/University

Dr. Robert D. Hisrich is the Bridgestone Professor of International Marketing and the Associate Dean of Graduate and International Programs at College of Business, Kent State University. He has been involved in the startup of numerous global companies. Professor Hisrich received his BA from DePauw University, his MBA, and Ph.D. degrees from the University of Cincinnati, and honorary doctorate degrees from Chuvash State University (Russia) and the University of Miskolc (Hungary). Prior to joining Thunderbird, Dr. Hisrich held the A. Malachi Mixon, III Chaired Professor of Entrepreneurial Studies at the Weatherhead School of Management, Case Western Reserve University.
Daniel Keoppel
Daniel Keoppel
SDO - Corporate

Senior Executive who has established corporate venture capital funds with two firms. Personally have invested over $100m in capital in 30 portfolio companies. Founded Verizon Ventures and built it to a team of 18 professionals deploying over $50m in capital annually. Developed a broad network with venture capital firms and international entrepreneurial communities. Advisor & mentor to startups, adjunct professor of Entreprenuership at Stevens Institute.
Mark Leigh
Mark Leigh
SDO - Corporate/Entrepreneur

Mark Leigh is working to accelerate profitability in organizations through improved sales, marketing, operations and planning. Currently he is developing start-up businesses as an active angel investor and board manager, using his experience to assist with commercialization of new products, evaluating business strategy and financial plans. Prior to his start-up and consulting work, Mark spent 20 years in the manufacturing industry as a senior executive managing businesses for both corporate and private equity ownership. He was the President of GSE Environmental where he worked to move the environmental plastics producer out of bankruptcy into a profitable entity focused on efficiency and growth. Before GSE, Mark was part of the management team at Orion Engineered Carbons which transformed the carbon black producing business unit of Evonik into a thriving stand-alone business publicly traded on the NYSE (OEC). During his tenure at Orion, Mark managed the Americas business and the global rubber business, providing leadership in pricing negotiations, strategic planning and resource efficiency. Mark spent his early career with Evonik Industries, a global specialty chemical manufacturer, managing the North American inorganic materials business where his customer and product knowledge led to improved margins and optimized capacity utilization. Mark has a Bachelor of Science degree in Chemistry from the University of Illinois and an MBA from Northwestern University, Kellogg School of Management.
Gene Linetsky
Gene Linetsky
SDO - Entrepreneur

Gene Linetsky is a founder of numerous startups, two of which had been acquired and one is still in business. He’s held technology executive positions at Mattel, Zone Labs, Check Point Software Technologies, Versal, and Poynt, among others.
Julee Meltzer
Julee Meltzer
SDO - Entrepreneur/University

Over the last 20 years she has had the opportunity of working with several medical technology related businesses in both the private and non-profit sector. These businesses have gone on to successfully raise millions of dollars in capital funding to bring life-changing medical device innovations to markets across the globe. She has assisted with raising start-up funds for a pain management center, kidney dialysis center, as well as a urologist medical device company. Throughout these experiences, she has recognized that it takes much more than just education and few years of practice, as with an ever-changing medical domain it takes excellent interpersonal and leadership skills to lead a team to success. She has also been able to demonstrate a successful track record of obtaining funds through the National Science Foundation (NSF) and the National Institutes of Health (NIH) for projects related to high-tech, medical business, healthcare, biology, and medical engineering. She currently works for Harvard University Medical School/ Bringham and Women’s Surgical Navigation and Robotics (SNR) Laboratory as a Senior Lab Manager to prepare and administer NIH medical device engineering grants.
Kevin Morningstar
Kevin Morningstar
SDO - Angel

Mr. Morningstar is s 35-year veteran of the medical device industry, most of that in quality, regulatory and clinical affairs. A lifelong entrepreneur and investor, Mr. Morningstar has been active in the Colorado startup ecosystem for over 15 years. He co-founded Silverglide Surgical Technologies, Inc., a Boulder surgical instruments business successfully sold to Stryker in a planned exit. More recently he was an investor and senior manager at ValveXchange, a heart valve start-up in Denver. He holds a B.S. in Electrical Engineering from Michigan State University and currently consults in the medical device industry, digital health community, and startup ecosystem. Kevin is a member of Rockies Venture Club where he serves as Mentorship Chair and as a general partner in the Rockies Venture Fund.
Valerie Rauluk
Valerie Rauluk
SDO - Entrepreneur

Based on forty years of startup/ technology commercialization experience and research, Vecat has developed a framework for increasing the probability of success of new endeavors. Driven by systematically building the capacity and infrastructure for success, services are tailored to individual circumstances and needs.
Robert Rea
Robert Rea
SDO - Corporate/Entrepreneur

Robert Rea, a founding member of Axcel Innovation, has over 25 years’ experience developing projects that include technical and economic feasibility studies, strategic plans, R&D resource allocation systems, environmental assessments, and business plans. These projects cover technology development, transportation, natural resource development, aerospace, defense, energy, technology commercialization and venture capital. In US Air Force R&D, Captain Rea served as Director of Planning for the Air Force Flight Dynamics Laboratory. He was a founder of Abt Associates, Inc, a government consulting firm in Cambridge MA which grew from four to 450 employees during his eight-year tenure. He was also the Deputy Director of the New Mexico Research and Development Institute focusing on energy resource development and venture capital. Mr. Rea then worked with SAIC where he conducted projects in environmental protection, transportation, and entrepreneurial ventures. After SAIC, he joined Technology Ventures Corporation in Albuquerque to link technology entrepreneurs with investment capital and joined one of his clients, a high-tech startup in plasma technology from Los Alamos National Laboratory, as VP/Chief Operating Officer. He was also an adjunct faculty member in the MBA programs of the University of Phoenix and Webster University in Albuquerque and Las Vegas, NV.
Mike Rinkunas
Mike Rinkunas
SDO - Entrepreneur

Most recently, Michael (Mike) Rinkunas was the Senior Platform and Acceleration Program Manager at Dreamit Ventures. There he refined growth, product commercialization, & investment strategies for early stage healthcare startups, spanning digital health & information technology products to medical devices & diagnostics. During his time at Dreamit, he accelerated ~50 healthcare companies, helped 20+ of those startups close investor funding rounds ranging from $250K to $5M, and curated introductions for the startups with industry experts, corporate partners & potential customers. Before his tenure at Dreamit, Mike previously founded and lead several boutique digital media & marketing companies. He specialized in the strategic planning and execution of large scale projects for a wide range of industries and clients. Mike holds both a Masters and Bachelors in Industrial Engineering from Lehigh University. When not accelerating businesses, he can often be found in the cab of a steam locomotive while volunteering as a railroad locomotive engineer and conductor at Steamtown National Historic Site..
Fred Rogers
Fred Rogers
SDO - Entrepreneur

Fred Rogers is a serial entrepreneur and has had a life-long passion for new technologies and the process of rapid and successful commercialization. Rogers was founder and president of Rogers & Associates Management Consultants, Ltd., from its inception in 1972, until its acquisition in 1985. He led the firm from being a startup to becoming an enterprise with 7 offices in the United States and 3 in Canada, over 200 employees. Rogers & Associates was a large scale systems developer for clients such as Shell Oil, Bank of America, The Government of British Columbia and American Airlines to name a few. During this period of developing innovative applications for computer technology Rogers became interested in the process of technology commercialization. After the sales of the company he was able to spend several years in the late 1980’s and early 1990’s developing the ideas and methodologies that would become the core of SUTI Holdings LP.
Victoria Scarborough
Victoria Scarborough
SDO - Corporate

Dr. Victoria Scarborough was with The Sherwin-Williams Co. for more than thirty years as the Program Director for the Global External Technology Team. This team has several responsibilities including identifying & leveraging technologies that address the global technical needs of Sherwin-Williams by scouting universities, the technical marketplace, search agencies, venture capital groups, and adjacent consumer product industries. Her lab team provides proof-of-concept research & data for technologies new to the paint & coatings industry. Dr. Scarborough has served as the Director of New Technology for the SW Diversified Brands Division, directed the R&D team for the Thompson’s ® Water Seal® brand and published and presented extensively on wood protection, water repellency and wood chemistry in addition to holding several patents in this area. Dr. Scarborough holds a Ph.D. in Biochemistry from the University of Tennessee.
Ashley Stevens
Ashley Stevens
SDO - University

The Focus IP Group provides a variety of consulting services in intellectual property matters, including serving as an Expert Witness services in intellectual property disputes, technology scouting, technology transfer and teaching the commercialization of early stage technologies.
For 15 years, he led Boston University’s Office of Technology Transfer. He then became Special Assistant to the Vice President for Research for two years before retiring from full time employment at BU. He remains a Lecturer in the Strategy and Innovation Department in Boston University’s School of Management, where he teaches two graduate-level, inter-disciplinary courses on Technology Commercialization. Before joining Boston University he was Director of the Office of Technology Transfer at the Dana-Farber Cancer Institute, a teaching affiliate of the Harvard Medical School.
During his tenure at Boston University, the Office of Technology Development spun out over 50 companies based on the University’s research, a number of which have raised substantial amounts of capital, and the University’s licensing income climbed steadily.
He has recently been appointed a Guest Professor at Osaka University, Japan, where he teaches G-TEC, an intensive summer course on technology commercialization.
Prior to entering the technology transfer profession, Dr. Stevens worked in the biotechnology industry for nearly ten years. He was a co-founder of Kytogenics, Inc., of which he is still a Director, was co-founder of Genmap, Inc., and was Vice President of Business Development for BioTechnica International. He started his career with The Procter & Gamble Company, where he held a number of positions in commercial development, sales, marketing, product management, strategic planning and acquisitions and mergers.
Glenn Vonk
Glenn Vonk
SDO - Corporate

Glenn Vonk has over 30 years’ experience leading technology developments in diagnostics, drug delivery, and medical devices including immunoassays, molecular diagnostics, detection systems, and new chemical entities. He established life sciences R&D at BD BioVenture Centre in Singapore leading to several commercialization programs in developing world diagnostics and biopharmaceutical manufacturing. Glenn is inventor of BD intellectual property used in drug delivery and diagnostics products. While in Singapore, he was responsible for infectious disease proof of concept clinical research in Thailand. While Director of Advanced Technology Glenn coordinated innovation resources at corporate R&D and sourced key technologies for BD’s strategic business needs. Glenn rapidly connects new technology options to significant business needs and processes to accelerate their progress to market.
Mark Vreeke
Mark Vreeke
SDO - Angel

Dr. Vreeke is a cofounder of the Chemical Angel Network. The Chemical Angel Network provides a source of capital for early stage firms that converge with the chemical sector in the materials, measurement and manufacturing space. Previously, Dr. Vreeke served as vice president of R&D for Rational Biotechnology, a Rational Systems spin-off. Rational Biotech’s mission was to speed the adoption of personalized medicine through the development of combined IVD and drug therapy products. Rational Biotech identified a novel route to the delivery of personalized therapy without the requirement of massive clinical trials. He also served as the Senior VP of R&D at Pepex Biomedical (St. Louis, MO). Pepex is an early stage medical device company specializing in developing, manufacturing and marketing disposable miniaturized electrochemical biosensors. He graduated from Calvin College with a BS in chemistry and went on to receive a PhD in analytical chemistry from the University of Texas at Austin. He is currently a member of the editorial advisory board of IVD Technology and is a visiting professor in the chemical engineering department at the Universitat Rovira i Virgili (Tarragona, Spain). He sits on several academic, industry, and corporate boards. Academic honors include a Dow Scholar, Welch Fellow and Woodrow Wilson Fellow.
Helena Wisniewski
Helena Wisniewski
SDO - University

Dr. Helena S. Wisniewski assumed the position of Vice Provost for Research and Graduate Studies and Dean of the Graduate School, at UAA in August 2011. She is President of Seawolf Holdings, a wholly owned subsidiary of UAA, and the Founding Director for the Arctic Domain Awareness Center (ADAC) a DHS National Center of Excellence. She has a breadth of senior executive and leadership experience in academia, the federal government, and private industry. She has an impressive record of leading technology innovation and has successfully launched and sold startup companies. She holds patents and has received awards for outstanding leadership, entrepreneurship, and significant contributions to scientific areas, including the 2002 Women in Technology Leadership Award for Entrepreneurship;the Award of Honor in Recognition of Extraordinary Leadership, Management, and Service from Lockheed Award for Special Achievement from the CIA, and for Special Recognition from DARPA. Recently she was selected as a Fellow of the National Academy of Inventors and will inducted in April 2016 at a ceremony in Washington, D.C.
Michael Wu
Michael Wu
SDO - Angel

Michael Wu brings 14 years of experience in venture capital, five years in technology commercialization, and eight years in product management. Prior to founding Blue Angel Partners (pre-seed funding on enabling technologies for “Internet of Things”), Michael was a Principal at Chart Venture Partners focusing on dual-use (with both commercial and defense applications), federally funded technologies in Communications, Cyber Security, Decision Analytics, Sensors, and Clean Energy. Prior to that, Michael founded Blue Angel Ventures in angel funding and co-founding or advisory roles at NC-based startups. Prior to entering venture capital, Michael held engineering and product management roles in fiber optics and wireless communications at Nortel, Ericsson and Nextel. Michael earned his MBA from Duke University-Fuqua, M.S. in Electrical Engineering and Graduate Certificate in Management of Technology from Georgia Tech, and B.S. in Electrical Engineering from Worcester Polytechnic Institute. Michael is also a registered patent agent and Certified Licensing Professional.
Don Zinn
Don Zinn
SDO - Entrepreneur

Don has 25 years of experience in building biotech, pharmaceutical and medical device companies, including fund raising, generating and cultivating relationships, developing and implementing business strategies and deal making. For the last 7 years Don led Business Development for Microbion Corporation taking the company from infancy to IPO / Acquisition ready. Previously he served as the CEO of Aursos, CEO and Co-Founder of AzoRx, Vice President of Business Development and Co-Founder for Genetic Immunity, Vice President of Business Development for Meridian Labs, and Founder and Business Operations for Artesian Therapeutics as well as Executive In Residence for the Apjohn Group. He served on the Board of Directors of Aursos, AzoRx, Artesian and Genetic Immunity. He holds a BS in Biology from the University of Maryland Baltimore County.
Robert Bennett
Robert Bennett
SDO - Corporate/Entrepreneur

Robert R. Bennett is an independent executive business strategic growth advisor specializing in making the impossible possible. He is a talented facilitator, mentor, entrepreneur, and implementer with a track record of results in line management positions prior to becoming an independent advisor. He serves as a trusted strategic advisor, and facilitator to leaders to enable them to clearly articulate a future growth or turnaround vision and strategy, and then engage their followers to achieve it. Bob is known for his ability to synthesize discussion to its essence and integrate seemingly disparate data and points of view together into agreement and action. He is a serial entrepreneur having started up three companies and mentoring 19 in the last two years. Bob serves a wide spectrum of worldwide organizations. His client base is a diverse mix of non-profit organizations, national governments, professional services firms, private equity firms, and private companies, as well as Fortune 500 organizations. Bob enjoyed a successful corporate career with Westinghouse Electric Corporation where he held roles in engineering, manufacturing and marketing rapidly transitioning into a variety of Executive Management roles, both domestic and international, before becoming an independent advisor and entrepreneur in 1998.

Michael Blaustein
Michael Blaustein
SDO - Corporate

Michael was previously Director of Corporate Venture Capital and Planning Director for Science and Technology at DuPont. He began his career at DuPont in Research & Development. where he held technology, marketing, and business leadership positions in DuPont Nonwovens and DuPont Advanced Fibers Systems until becoming Business Director for DuPont Nonwovens in Europe. In 2000 he became Planning Director for DuPont Central Research and Development, and added responsibility for DuPont’s venture capital investments in 2006. He worked across DuPont on R&D portfolio and innovation management and with external parties on collaborative research and open innovation. Michael holds a BA in chemistry from Columbia University and a Ph.D. in chemistry from Yale University. Michael Blaustein is Principal of the MAB Innovation Group. He is working with early stage companies and the entrepreneurial ecosystem on business development, innovation strategy, and corporate collaborations and venture capital investments, and with larger organizations on strategy and innovation. He serves as a member of the Ben Franklin Technology Partners of Southeastern Pennsylvania materials science investment advisory board.

Eugene Buff
Eugene Buff
SDO - Corporate/Entrepreneur

Dr. Eugene Buff is a Registered Technology Transfer Professional (RTTP) and Certified Licensing Professional (CLP) with over twenty years of combined scientific, consulting and management experience. He has substantial expertise in a wide variety of industries, including but not limited to healthcare, biotechnology, medical devices, consumer products, materials and chemical manufacturing. Dr. Buff is a Founder and President of Primary Care Innovation Consulting (PCIC), a new type of innovation management and business development firm supporting companies’ growth through open innovation. PCIC provides technology strategy consulting for both large and small companies globally and has unique access to cutting edge innovation at universities, incubators and accelerators worldwide. Its signature product, Innovation Navigator™ offers comprehensive business development support by combining known theories (such as Lean Start Up, “Jobs-To-Be-Done” and Disruptive Innovation) with years of successful consulting practices. Dr. Buff also designed and teaches “Customer Driven Technical Innovation for Engineers”, a core course for Entrepreneurship Minor at Northeastern University, Boston. Dr. Buff earned his Master degree in Biochemistry as well as his Medical Doctor degree from Russian State Medical University. He is a Ph.D. in Genetics and is a coauthor of 14 papers in peer reviewed international journals. Eugene is an active member of the Licensing and Technology Transfer community and serves on several committees and task forces at AUTM and LES. He is a member on many consulting and professional network organizations and often mentors and presents on issues of Entrepreneurship, Intellectual Property, Innovation and Technology Transfer both in US and internationally.

Ron Epperson
Ron Epperson
SDO - Entrepreneur/University

Ron Epperson is a seasoned energy, chemical and clean tech entrepreneur with over 35 years of experience as a corporate executive, consultant, entrepreneur, investor and mentor. Ron spent 20 years at Royal Dutch /Shell where he was responsible for commercializing seven new energy and chemical technologies. He also built and managed an international licensing business that successfully licensed technologies into Korea, Japan, Mexico, Spain, Austria, Germany, France and South Africa. Ron’s chemical expertise includes alpha olefins, synthetic fatty alcohols, ethylene oxide and ethylene glycol, surfactants, lubricant and fuel additives, polyolefins, polyesters, hydrogen and syn gas. As a consultant, Ron was the leader of Intellectual Property practices at the international firms Ernst & Young and Grant Thornton. As an entrepreneur, he has had C level leadership roles in several startups that include renewable energy project development, renewable energy financing, petrochemical project development, electric motor technology, hydrogen fuel technology, energy storage, fintech and water clean up. As an investor, Ron managed corporate venture teams at Shell, and has been an angel and A Round investor in numerous clean tech companies covering renewable energy production, energy storage, advanced bio materials, carbon fiber composites, enhanced oil and gas recovery, environmental mitigation, novel gas fired power generation and energy efficiency.

John Fraser
John Fraser
SDO - University

President of Burnside Development & Associates LLC, Mr. Fraser now teaches academic technology transfer in several countries in South East Asia with colleagues on behalf of WIPO. He consults to the Serbian Innovation Fund on accelerating technology commercialization in the four largest Serbian universities on behalf of the World Bank. He is the Entrepreneur-in-Residence at the National Institutes for Standards and Technology (NIST), near his home in Bethesda, Maryland, amongst other consultancies. He left Florida State University in 2014, from his position as Assistant Vice President - Research and Economic Development and Executive Director of the Office of IP Development & Commercialization, FSU, Tallahassee, Florida. He was elected the 2006/2007 President of AUTM, the global association of academic technology transfer professionals and remains active in Association activities. Prior to FSU, he co-founded three companies and assisted entrepreneurs launch another twelve technology based firms. At FSU, he served as midwife for 30+ spin-out companies. Mr. Fraser holds a Masters Degree in Biochemistry from the University of California - Berkeley.

Steve Freilich
Steve Freilich
SDO - Corporate

Steve is a former DuPont executive. He developed and implemented science strategies that supported corporate growth in the mid-term and long-term. He was also a spokesperson for DuPont materials science to the external community, including national labs, customers, partners, and academic institutions. He generated multi-billion dollars in new product revenue by building and implementing multi-generational strategies for energy materials. He also established technology strategies for existing and new company businesses, leading to growth opportunities in rapidly growing, technology-rich markets using cutting-edge science and engineering.

Scott Garber
Scott Garber
SDO - Angel

Scott Garber's business career has constantly evolved from a very young age, but has always focused on solving specific challenges through innovative approaches and consumer experiences. A teenage beanie babies business and Pokemon portal eventually blossomed into Puppystock (2005-2007), an online marketplace with customized pet products. While Puppystock had tens of thousands of customers across six continents and was eventually acquired in 2007, FriendTones (2007-2008) disrupted the way content could be shared across nearly any network and device. Although FriendTones had hundreds of thousands of users and was acquired in 2008, it was ultimately before it's time and a very powerful education for all future roles. Since his ventures, Scott has directed large software development and deployment projects for Government clients (2008-2011), served as a strategy consultant for the deputy director of an intelligence agency (2009-2010), and founded/operated an international venture fund (2011-2014). More recently, Scott was the deputy head of corporate strategy and corporate development for a multi billion revenue company (2015-2017) and an entrepreneur-in-residence at AARP (2017-2018), focused on designing and disrupting the way seniors age in place. Scott has always been very passionate about building and helping startups - he's been an active angel investor in the mid-atlantic region (16 total deals) and is very excited to jump start the mid-atlantic startup ecosystem as the current Operations Director of Baltimore Angels.
David Hayes
David Hayes
SDO - Entrepreneur

David Hayes is a serial entrepreneur, innovator, and university instructor with an extraordinary record of business creation. Mr. Hayes has an advanced educational background and proven, dynamic startup leadership and visioning capabilities. Mr. Hayes has much experience and success in both business and academic environments.

Arthur Helmstetter
Arthur Helmstetter
SDO - Entrepreneur

Art has been at the crossroads of business and technology for his entire career. This began with a first of its kind waste to energy plant in the 70s, hazardous solvent reuse as fuel in cement kilns in the 80s, outsourced chemical reduction services in the 90s, and then development of environmentally friendly chemicals and processes. He has been involved in starting 3 businesses from scratch, and introduced 2 other innovative business models in existing companies. During this time he has worked with university professors and students in SBIR/STTR projects, ICorps mentoring, and mentoring co-op engineering students in business projects for 8 years.

Isaac Maya
Isaac Maya
SDO - Corporate/Entrepreneur

Dr. Maya is an expert in executive management and strategic planning, with successes in commercial start-up/early stage high technology businesses and university research centers, and in leading high technology industrial and academic R&D and technology transfer/transition. He has practical in-field experience in DOD/DHS/industrial/commercial & academic environments. Dr. Maya is proficient in a broad spectrum of technical and non-technical disciplines, including nuclear engineering science, program/project management, information technologies, risk and decision analysis, economics assessment, and social sciences. His technical preparation complements practical corporate experience with fiscal P&L responsibility.

David McFeeters-Krone
David McFeeters-Krone
SDO - Corporate/Entrepreneur

David McFeeters-Krone is an experienced commercialization executive with over 25 years of experience at MIT, NASA, and Intel. He started his firm in 2001 to facilitate R&D business development with between institutions and industry. His clientele includes Sharp Technology Ventures, P&G, Deloitte, DoD, NASA, many smaller firms, various research hospitals, and the ManufacturingUSA Institutes. He has served on NSF SBIR review committees, and prepared winning NSF SBIR, NIST, Business Oregon and other grant proposals. He has leveraged his knowledge of technology, business processes and relationships to establish dozens of strategic R&D partnerships. His technical breadth spans alternative energy to armored glass and software to sand flies. He has created technical partnerships with the U.S. Air Force, U.S. Army, U.S. Navy, USDA, DHS, NASA, and DoE as well as relationships with NIST, FAA, and DHS. In the course of his practice, he has reviewed dozens of commercialization plans, founded two successful companies (Scribe-X, Rute Foundations), is an adjunct professor at Portland State University, and serves on the advisory board of several firms (Innovation Assets Group, Rute Foundations, Kerstech, TangiTek, and Oregon Inc.). He speaks regularly on Open Innovation and Technology Commercialization. He holds a Physics degree from the University of Michigan and an MBA from the University of Pittsburgh..

Brian McIlroy
Brian McIlroy
SDO - Corporate

Brian McIlroy, Ph.D., took on the role of new executive director of the Buffalo Institute for Genomics and Data Analytic at the University at Buffalo in April 2016. As executive director of BIG, Dr. McIlroy will develop and implement a comprehensive plan for advancing BIG’s mission, with a focus on driving innovation and generating economic impact through industry collaboration. He will lead the team at BIG in engaging industry and other partners on projects that transform genomic research advances into tools for treating, preventing, managing and diagnosing disease. Brian was recruited to GE Global Research in May 2007 as the Senior Bioinstrumentation Leader. Brian was responsible at GRC for advanced technology for four business units within GEHC – Interventional Systems, Life Care Solutions, Ultrasound & Surgery. Leading a group of approximately sixty technologists at GE Global research and responsible for the inception & development of the advanced technology roadmap for this group. Brian’s current role focus’s on commercial avenues to monetize GE’s intangible assets through partnership and licensing agreements with partners. Overall, Brian has over 20 years’ experience in all aspects of medical device development together with management of clinical trials ranging from preclinical through phase III FDA controlled global trials.

Kevin McLaughlin
Kevin McLaughlin
SDO - Entrepreneur/University

Kevin McLaughlin brings over 30 years of experience in technology commercialization and executive leadership, working for Motorola, Cray Research, SGI, Cisco Systems and Avid technology. McLaughlin recently served as adjunct lecturer for the University of Arizona, McGuire Center for Entrepreneurship. He currently works as a Startup Development Officer with NCET2 (www.ncet2.org) and Mentor in Residence with Tech Launch Arizona on early technology assessments in the areas of optics, engineering, and physical sciences. McLaughlin is Co-founder and CEO for Luma.ai (www.lum.ai) a UA startup and a founding advisor for Pitch Vantage (www.pitchvantage.com). McLaughlin holds degrees in physics and business.

Arundeep Pradhan
Arundeep Pradhan
SDO - Entrepreneur

Mr. Pradhan is a pioneer in the field of technology transfer. He is a former president of the Association of University Technology Managers (AUTM) and the AUTM Foundation and was on the on the AUTM Board of Trustees from 2006 to 2010. Mr. Pradhan is an expert in negotiation, strategy, management and operations and forging multi-partner, multi-national alliances. His experience spans a number of industrial sectors. He has been involved with the launch of over 75 startups and currently consults with entrepreneurs to create and refine business and commercial development plans, raise capital, and mentor entrepreneurs. Mr. Pradhan also works closely with several universities on technology transfer program development and provides training and workshops in several countries.

Stephen Rapundalo
Stephen Rapundalo
SDO - Entrepreneur

Transformed a marginal statewide, non-profit association into a robust organization and recognizable brand with enhanced services, resources, education, and communications. Implemented essential governance, financial and operational processes, as well as a much-admired advocacy capability. Increased membership and financial stability. Pharmaceutical R&D, management and strategic planning - led or contributed significantly to numerous multi-disciplinary discovery programs that developed new drug targets and key products like Lipitor®, Accupril®, Lyrica® in the cardiovascular and other therapeutic areas. Developed and applied highly innovative technologies. Elected official and community leader – helped develop and lead numerous policy initiatives, budgets, labor negotiations, risk management projects, financial governance processes, municipal infrastructure improvements, and economic development activities over >25-year span with tangible physical and operational outcomes that improved quality of life.
Morris Sandler
Morris Sandler
SDO - Entrepreneur

Morris is a highly accomplished and proven Serial Entrepreneur/Investor, C-Suite Officer, Senior Executive, Consultant, and Board Member with significant success in technology, financial services, merchant and investment banking, asset management, distressed debt, green energy, cleantech, solar, geothermal, smart grid, renewables, mobile toxic waste management, pharma, telecom, internet, manufacturing, import/export, consumer goods (CPG), metals, private equity (PE), venture capital (VC), and consulting. Leveraging extensive experience in international business and capital raising, he is a valuable asset for a range of startup to midsize companies and social enterprises looking for acumen in market analysis, strategic planning, fundraising, and financing. His broad areas of expertise include corporate development and finance; executive consulting and management; leadership; entrepreneurship; investor relations; financial analysis, models, and structures; business strategy, planning, and development; competitive market analysis; emerging markets; mergers and acquisitions; due diligence; valuation; feasibility; integration; IPO; and LBO. As a Serial Entrepreneur/Investor and Managing Partner over 17 years, Morris has founded and directed multiple successful private energy, private equity, and telecom ventures focused on green and solar energy, geothermal, and biomass. He structured and marketed a $500M private equity fund to acquire small to midsize alternative energy companies held for long-term; developed a $320M waste to energy project in Guatemala; and served as Chair, Interim CEO, and Consultant for several geothermal and smart grid entities.

Laura Savatski
Laura Savatski
SDO - University

Laura currently serves as Technology Transfer Officer for Versiti, a set of blood centers in the Midwest which includes the Blood Research Institute. She has broad experience in bringing inventions to market through her roles as a scientist, a general research administrator, a co-founder of a biotech start-up, and in her current role in technology transfer. Her early career in medical research focused on vaccine trials, molecular virology, stem cell biology, transplant/oncology, and cellular assays. Her past roles include Vice President and Chief Operating Officer for Prodesse, a molecular infectious disease diagnostics company now part of Hologic. She is currently serving on the board for the Alliance of Technology Transfer Professionals, helping set the accreditation standards for the field. Additionally, she is a board member for AUTM, the largest international society for tech transfer and knowledge transfer professionals.

John Seman
John Seman
SDO - Corporate/Entrepreneur

John Seman is CEO of REVITALE Pharma, a clinical stage company advancing a transformative treatment for anemia of chronic inflammation licensed from Brigham Young University. Mr. Seman began his career in global life science corporations working for E. R. Squibb & Sons and multiple divisions of Johnson & Johnson, holding various management positions in sales, marketing and business development, and executive management at Corning. During his tenure at Squibb, he was a team member responsible for the introduction a new cardiovascular drug that achieved highest first sales in company history. At Johnson & Johnson, he managed a portfolio of eight biotech products at various stages of pre-clinical and clinical development, and actively participated in the licensing and acquisition of multiple pharmaceutical products. His leadership experience at Corning includes expansion of central laboratory services into the European market and developing a marketing strategy to increase profitability within a growing base of repeat customers. The past 20 years have been spent in entrepreneurial startups where he built an innovative technology based company, AVANTEC, to accelerate the receipt of clinical trial data from investigator sites, securing over $10M from multiple rounds of financing; boot strapped, tripled revenue, and sold a reimbursement services company, HealthBridge; and secured seed funding from angel investors for a preclinical research company, PhysioGenix, transforming a SBIR funded company into a revenue generating company.

Steve Socolof
Steve Socolof
SDO - Angel

Stephen Socolof is a Managing Partner of New Venture Partners LLC (“NVP”). With over $700 million under management and offices in the US and Europe, NVP is the leading global venture capital firm specializing in corporate spinout venturing. NVP works closely with corporations to commercialize and scale up new innovations as standalone ventures. NVP itself was spun out of Lucent Technologies, where it had been an incubator for spinout opportunities from Bell Labs. NVP focuses on communications and information technologies as well as energy and materials. In addition to Steve’s firm management responsibilities, he leads deals in semiconductors, software, storage, and wireless technologies. He is currently a director of Alverix, CrossFiber, EverSpin Technologies, GainSpan Corporation, Own Products, and a board observer of Intelleflex. He was recently a director of Sychip, Inc. (sold to Murata) and an observer of Flarion Technologies, Inc. (sold to Qualcomm), and Silicon Hive (sold to Intel). Steve holds a BA in Economics and a BS in Mathematical Sciences from Stanford University and received his MBA from the Amos Tuck School at Dartmouth College, where he was a Tuck Scholar. He currently serves on the board of the Center for the Study of Private Equity at the Tuck School.

Todd Stave
Todd Stave
SDO - Entrepreneur

Entrepreneur with proven success in business start ups, business expansion, and turn arounds. Core strengths include designing and executing customer discovery plans, recognizing and exploiting hidden opportunities and obstacles, engineering, negotiating and closing complex investor and partnership transactions and finding creative solutions to enhance any company’s top and bottom lines.

Robin Stears
Robin Stears
SDO - Corporate/University

She holds a PhD from SUNY at Stony Brook and during her thesis research she was a selected attendee of the highly competitive Physiology Course at Woods Hole, MA. She was also selected as a post doctoral attendee of the NSF funded international scientist training program titled 'Biology of Antarctic Organisms' which was held at McMurdo Base, Antarctica. She started a post-doctoral fellowship looking at population genetics of coral reef sea urchins in Hawaii, which was completed at Harvard University. Following this, she completed a fellowship at Harvard Medical School and Brigham and Women's Hospital looking at adaptations to osmotic stress in renal cells. During this time, her lab was a first adopter of nascent technology for cDNA gene chips and she invented a signal detection system for cDNA arrays (Gensophere cDNA detection system). Following this fellowship, she ran the transcriptional profiling facility at the Cambridge Genomics Center for Aventis Pharmaceuticals (now Sanofi Pharma). From there she was recruited to a start-up company in Sunnyvale, CA where she developed new products and built a Custom Services Division for the company (and increased company gross profits over 15% in the first 18 months). This included hiring staff, creating protocols and SOPs, as well as performing marketing and sales. Once the new division was up and running, she accepted a position at Bio-Rad Labs as a Global Marketing Manager for their new gene arrays product line, and was soon promoted to Business Development Manager for the Gene Expression Division. From there she was recruited to Intel as a Senior Business Development Manager for their Digital Health Group as well as their Life Sciences research group. The Digital Health Group was successfully spun out as a joint venture with GE Healthcare after which she did consulting for early biotech stage start-up companies in the New York area. From there she accepted a position as in Intellectual Property Officer for UC Davis in 2012 where she works to evaluate new technologies, manage patenting, marketing and licensing as well as support start-up companies. She's been an invited judge for UCD's Big Bang competition as well as a mentor for the Biomedical + Engineering Entrepreneurship Academy.

Cheryl Vickroy
Cheryl Vickroy
SDO - Entrepreneur/Angel

Cheryl Vickroy, MBA, is a seasoned entrepreneur with broad functional expertise in business (from finance to marketing to HR). She worked 15 years in industry and has since led/managed multiple successful high-growth, early stage, technology-based firms. She brings differing perspectives on commercialization of innovation – from having been a successful entrepreneur to having invested in select tech-based firms to mentoring other entrepreneurs. Cheryl is an exceptional strategist and has built management teams, developed milestones and projections and dsicovered new markets. She currently consults in acquisition of SBIR/STTR funding, using Lean Startup techniques and time-tested commercialization strategies. She has helped her own and other firms acquire over $50M, twice served as an NSF iCorps mentor and has a nationwide network of contacts across industry domains.

Please publish modules in offcanvas position.